Skip navigation
  • Home
  • Browse
    • Communities
      & Collections
    • Browse Items by:
    • Publication Date
    • Author
    • Title
    • Subject
    • Department
  • Sign on to:
    • My MacSphere
    • Receive email
      updates
    • Edit Profile


McMaster University Home Page
  1. MacSphere
  2. Departments and Schools
  3. Faculty of Health Sciences
  4. Pediatrics
  5. Pediatrics Publications
Please use this identifier to cite or link to this item: http://hdl.handle.net/11375/26207
Title: Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association
Authors: Venkatesan T
Levinthal DJ
Tarbell SE
Jaradeh SS
Hasler WL
Issenman RM
Adams KA
Sarosiek I
Stave CD
Sharaf RN
Sultan S
Li BUK
Department: Pediatrics
Keywords: abortive treatment;cyclic vomiting;emergency department;management;prophylaxis;Adult;Antiemetics;Consensus;Gastroenterology;Humans;Societies, Medical;Treatment Outcome;United States;Vomiting
Publication Date: Jun-2019
Publisher: Wiley
Abstract: The increasing recognition of cyclic vomiting syndrome (CVS) in adults prompted the development of these evidence-based guidelines on the management of CVS in adults, which was sponsored by the American Neurogastroenterology and Motility Society (ANMS) and the Cyclic Vomiting Syndrome Association (CVSA). GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) framework was used and a professional librarian performed the literature search. The expert committee included the President of the CVSA who brought a patient perspective into the deliberations. The committee makes recommendations for the prophylaxis of CVS, treatment of acute attacks, diagnosis, and overall management of CVS. The committee strongly  recommends that adults with moderate-to-severe CVS receive a tricyclic antidepressant (TCA), such as amitriptyline, as a first-line prophylactic medication and receive topiramate or aprepitant as alternate prophylactic medications. Zonisamide or levetiracetam and mitochondrial supplements (Coenzyme Q10, L-carnitine, and riboflavin) are conditionally recommended as alternate prophylactic medications, either alone or concurrently with other prophylactic medications. For acute attacks, the committee conditionally recommends using serotonin antagonists, such as ondansetron, and/or triptans, such as sumatriptan or aprepitant to abort symptoms. Emergency department treatment is best achieved with the use of an individualized treatment protocol and shared with the care team (example provided). The committee recommended screening and treatment for comorbid conditions such as anxiety, depression, migraine headache, autonomic dysfunction, sleep disorders, and substance use with referral to appropriate allied health services as indicated. Techniques like meditation, relaxation, and biofeedback may be offered as complementary therapy to improve overall well-being and patient care outcomes.
URI: http://hdl.handle.net/11375/26207
metadata.dc.identifier.doi: 10.1111/nmo.13604
ISSN: 1350-1925
1365-2982
Appears in Collections:Pediatrics Publications

Files in This Item:
File Description SizeFormat 
Venkatesan_et_al-2019-CVS guidelines.pdf
Open Access
1.27 MBAdobe PDFView/Open
Show full item record Statistics


Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.

Sherman Centre for Digital Scholarship     McMaster University Libraries
©2022 McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4L8 | 905-525-9140 | Contact Us | Terms of Use & Privacy Policy | Feedback

Report Accessibility Issue